MUSCLE ATROPHY: INTEGRATIVE MOLECULAR MECHANISMS AND TRANSLATIONAL CHALLENGES
Abstract
Skeletal muscle loss is often characterized as a loss of mass and strength, but simply labeling it "atrophy" doesn't fully capture its clinical complexity. Whether it's due to aging, chronic disease, or bed rest, the rate and severity of muscle loss vary from patient to patient. This variability demonstrates that the traditional view of protein breakdown exceeding synthesis is necessary, but not complete.
References
1. Glass DJ. Signaling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol. 2003;5(2):87–90.
2. Bodine SC, Baehr LM. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1. Am J Physiol Endocrinol Metab. 2014;307(6):E469–E484.
3. Sandri M. Autophagy in skeletal muscle. FEBS Lett. 2010;584(7):1411–1416.
4. Bonaldo P, Sandri M. Cellular and molecular mechanisms of muscle atrophy. Dis Model Mech. 2013;6(1):25–39.
5. Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J. 2013;280(17):4294–4314.
6. Egerman MA, Glass DJ. Signaling pathways controlling skeletal muscle mass. Crit Rev Biochem Mol Biol. 2014;49(1):59–68.
7. Cohen S, Nathan JA, Goldberg AL. Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov. 2015;14(1):58–74.
8. Fanzani A, Conraads VM, Penna F, Martinet W. Molecular and cellular mechanisms of skeletal muscle atrophy: an update. J Cachexia Sarcopenia Muscle. 2012;3(3):163–179.
9. White JP, Puppa MJ, Sato S, et al. IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia. FASEB J. 2012;26(10):4390–4400.
10. Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev. 2009;89(2):381–410.
11. McPherron AC, Lee SJ. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci USA. 1997;94(23):12457–12461.
12. Stitt TN, Drujan D, Clarke BA, et al. The IGF-1/PI3K/Akt pathway prevents muscle atrophy by inhibiting FOXO. Mol Cell. 2004;14(3):395–403.
13. Romanello V, Sandri M. Mitochondrial quality control and muscle mass maintenance. Front Physiol. 2016;6:422.
14. Li YP, Reid MB. NF-κB mediates the protein loss induced by TNF-α in skeletal muscle. FASEB J. 2000;14(13):2091–2098.
15. Powers SK, Wiggs MP, Duarte JA, Zergeroglu AM, Demirel HA. Mitochondrial signaling in disuse muscle atrophy. J Appl Physiol. 2012;113(2):238–245.
16. Argilés JM, Busquets S, Stemmler B, López-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014;14(11):754–762.
17. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus. Age Ageing. 2010;39(4):412–423.
18. Larsson L, Degens H, Li M, et al. Sarcopenia: aging-related loss of muscle mass and function. Physiol Rev. 2019;99(1):427–511.
19. Wolfe RR. The underappreciated role of muscle in health and disease. Am J Clin Nutr. 2006;84(3):475–482.
20. Phillips SM, Winett RA. Uncomplicated resistance training and health-related outcomes. Curr Sports Med Rep. 2010;9(4):208–213.
